Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
afamelanotide (Scenesse) (1 trial)
Protoporphyria, Erythropoietic (Phase 3)
Trials (1 total)
Trial APIs (1 total)